HUM HUMANA INC
Price Chart
Executive Summary
Humana filed an 8-K under Item 7.01 to reaffirm its FY 2026 guidance of at least $8.36 GAAP EPS and at least $9.00 adjusted EPS, consistent with the April 29, 2026 press release. The reaffirmation accompanies a month-long investor roadshow (June 1–30, 2026). No new financial data or changes to outlook were provided.
Actionable Insight
The reaffirmation removes near-term guidance uncertainty but provides no catalyst. Monitor the investor roadshow for any off-script commentary on Medicare Advantage enrollment trends or medical cost trends, which are the key swing factors for Humana's 2026 results.
Key Facts
- FY 2026 GAAP EPS guidance reaffirmed at at least $8.36
- FY 2026 adjusted (non-GAAP) EPS guidance reaffirmed at at least $9.00
- Guidance is unchanged from the April 29, 2026 press release
- Management is meeting investors and analysts from June 1 to June 30, 2026
- Reconciliation: GAAP EPS $8.36 + $0.30 amortization - $0.28 put/call adjustments + $0.81 value creation initiatives - $0.19 cumulative net tax impact = adjusted EPS $9.00
Financial Impact
No new financial data; existing guidance of at least $8.36 GAAP EPS and at least $9.00 adjusted EPS for FY 2026 reaffirmed.
Risk Factors
- No change to guidance — any deterioration in fundamentals since April 29 is not reflected
- GAAP EPS guidance subject to change due to ongoing value creation initiatives, per the filing
- Reaffirmation does not address potential headwinds from Medicare Advantage rate changes or utilization trends
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000049071-26-000027 |
| Document: 0000049071-26-000027-index-headers.html | 0000049071-26-000027 |
| Document: 0000049071-26-000027-index.html | 0000049071-26-000027 |
| Document: 0000049071-26-000027.txt | 0000049071-26-000027 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
4d ago
|
8-K
| — | awaiting T+20 | — | — |
|
Apr 10, 2026
8w ago
|
8-K
| $197.53 $274.15 | ▲ +38.79% | ▲ +31.06% | $350.08 (+77.23%) |
|
Mar 6, 2026
13w ago
|
DEFA14A
| $179.09 $182.71 | ▲ +2.02% | ▲ +4.07% | $350.08 (+95.48%) |
|
Mar 2, 2026
13w ago
|
Court Ruling
| $187.00 $166.00 | ▼ −11.23% | ▼ −3.29% | $350.08 (+87.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access